Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens.
Arribillaga L, Echeverria I, Belsue V, Gomez T, Lozano T, Casares N, Villanueva L, Domingos-Pereira S, Romero PJ, Nardelli-Haefliger D, Hervás-Stubbs S, Sarobe P, Rodriguez MJ, Carrascosa JL, Zürcher T, Lasarte JJ.
Arribillaga L, et al. Among authors: gomez t.
J Immunother Cancer. 2020 Jun;8(1):e000704. doi: 10.1136/jitc-2020-000704.
J Immunother Cancer. 2020.
PMID: 32581060
Free PMC article.